P4-C4 · Export Controls → Domestic Substitution¶
Core One-Liner
Regulatory actions have a 6-24 month lag — short-term "obvious losers" may be offset by other factors, and domestic substitution in banned regions becomes a new thesis.
Real Public Cases — Use Part 3 Tools to Analyze 5 Real Events
P4-C4. All based on public data (U.S. Department of Commerce announcements + NVDA earnings + Huawei / SMIC public data).
1. Event: 2022-2026 U.S. AI Chip Export Controls on China — 3 Rounds¶
| Round | Time | Content | Market Reaction at Time (NVDA) |
|---|---|---|---|
| Round 1 | 2022/10 | Ban A100 / H100 sales to China | NVDA -10% (short-term) |
| Round 2 | 2023/10 | Ban H800 (customized throttled version) + AMD MI300 | NVDA -7% (short-term) |
| Round 3 | 2024/12 - 2025 | Restrict investment in China affiliates + ASML EUV not sold | NVDA +3% (already priced) |
→ Each round caused short-term panic, but **NVDA's total revenue from 2022→2025 still grew +400%+**. Why?
2. Four Dimensions of What Actually Happened¶
2.1 NVDA Lost ~25% of China Market¶
| Time | China as % of NVDA Revenue |
|---|---|
| 2022 (pre-controls) | 25% |
| 2024 | ~7% (H20 restricted version + prior inventory) |
| 2025 | < 5% |
→ Lost 20% revenue. But...
2.2 NVDA's Other Markets Filled the Gap¶
- Stargate $500B (P4-C3) U.S. capex explosion
- European sovereign AI (Mistral / sovereign cloud)
- UAE / Saudi sovereign funds ($100B+ committed)
- Japan / Korea AI (Softbank + Kakao)
→ NVDA 2024 revenue +126% YoY, far exceeding the 25% lost in China.
2.3 China's Domestic Substitution Emerged¶
Huawei Ascend 910B/C: - 2022: First generation not viable - 2023: Ascend 910B matured, performance close to A100 - 2024: Ascend 910C performance close to H100 (but process lags at 7nm/5nm) - Customers: Alibaba / ByteDance / Huawei Cloud
SMIC: - 2023: 7nm mass production (despite ASML not selling EUV, using DUV multi-patterning) - 2024: Yield 30%+ (vs TSM 70%+, but able to ramp) - Revenue +30%+
YMTC / CXMT: - Domestic HBM mass production 2026+ - Domestic DRAM / NAND already mature
2.4 DeepSeek Trained GPT-4 Level Model Using H800 + Algorithm Efficiency (P4-C1)¶
Proves banning chips ≠ banning capability. Algorithm + efficiency breakthroughs can compensate partially.
3. P3-C4 Multi-PM Perspectives¶
| PM | NVDA Impact View | Beneficiary Candidate View |
|---|---|---|
| Value PM | China lost, long-term unrecoverable | NVDA's diversified customer base spreads risk |
| Growth PM | Total revenue rising, temporary loss compensated | SMIC / Huawei rising, but hard to invest publicly |
| Macro PM | Geopolitical escalation, medium-to-long term irreversible | U.S.-China AI dual-track development (split market) |
3 perspectives combined: **NVDA's short-term negative is offset by other markets, long-term China market permanently lost** (must accept).
4. Lesson — Regulatory Lag + Substitution Effect¶
4.1 Regulatory Actions Lag 6-24 Months¶
| Event | Immediate Reaction | Real Impact (12-24 months later) |
|---|---|---|
| 2022/10 Round 1 controls | NVDA -10% | NVDA revenue 2023 +126% |
| 2023/10 Round 2 | NVDA -7% | NVDA revenue 2024 +120% again |
| 2024/12 Round 3 | +3% (already priced) | TBD |
→ Control announcement ≠ immediate impact. Companies have lead time to adjust (Inventory / alternative markets).
4.2 Substitution Effect¶
Banned regions develop domestic alternatives: - Huawei Ascend (replaces H100) - SMIC 7nm (replaces TSM) - YMTC HBM (replaces SK Hynix / Micron China share)
→ Domestic substitution companies rise, but most foreign investors can't invest (Huawei private, SMIC HK listed but illiquid).
4.3 Dual-Track¶
Next 5-10 years, AI industry splits in two: - U.S. + allied markets: NVDA / TSM / ASML / OpenAI - China market: Huawei / SMIC / DeepSeek
No cross-penetration. Investors must pick a side — can't own globally.
5. What Your Thesis Should Learn¶
- Control announcements treat as short-term panic, not long-term thesis break — see if the company can fill the gap
- Banned regions = new window for domestic substitution thesis (but public investment hard)
- Cross-region exposure is risk — NVDA's 25% China, lost, but total revenue still grew due to diversification
- 2026+ monitor: Semiconductor equipment export controls expansion (ASML / AMAT) / 5nm equipment expansion / cross-border investment restrictions
6. Next → P4-C5¶
You've seen the geopolitical wildcard. Final case: **Buffett used his 5-step framework, why didn't he buy NVDA**.
→ P4-C5 · Buffett's Forensic on Not Buying NVDA — Use P3-C2 Buffett's 5 steps to analyze NVDA item by item.